MetLife, Inc.METNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -3.09% | +14.85% | -1.80% | -7.74% | +29.14% |
| Gross Profit Growth | +53.25% | +5.10% | +3.46% | -46.08% | +49.47% |
| EBITDA Growth | +35.54% | +23.15% | -14.39% | -34.21% | -15.85% |
| Operating Income Growth | +46.76% | +29.57% | -18.47% | -39.32% | -19.12% |
| Net Income Growth | +109.39% | +9.00% | -22.94% | -33.23% | -36.35% |
| EPS Growth | +132.47% | +16.22% | -18.75% | -32.42% | -34.64% |
| EPS Diluted Growth | +131.17% | +16.36% | -19.53% | -32.60% | -34.27% |
| Weighted Average Shares Growth | -6.63% | -5.66% | -5.59% | -4.95% | -4.47% |
| Weighted Average Shares Diluted Growth | -6.38% | -5.68% | -5.55% | -4.92% | -4.72% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -10.35% | +83.08% | -37.34% | -14.44% | +57.71% |
| Free Cash Flow Growth | -10.35% | +83.08% | -37.34% | -14.44% | +57.71% |
| Receivables Growth | +1.90% | +7.64% | +1.71% | +30.44% | +59.44% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -1.47% | +1.59% | +3.95% | +2.09% | +9.48% |
| Book Value per Share Growth | -2.07% | +2.12% | +7.60% | -1.41% | +8.31% |
| Debt Growth | -0.60% | -0.17% | +8.41% | +5.24% | +3.28% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -8.66% | +3.37% | +4.39% | +2.62% | -100.00% |